BlackRock Institutional Trust’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $87.7M | Buy |
2,266,340
+115,391
| +5% | +$4.47M | 0.01% | 1010 |
|
|
2016
Q3 | $109M | Buy |
2,150,949
+136,277
| +7% | +$6.9M | 0.02% | 833 |
|
|
2016
Q2 | $91.6M | Sell |
2,014,672
-16,995
| -0.8% | -$772K | 0.01% | 899 |
|
|
2016
Q1 | $80.4M | Buy |
2,031,667
+902
| +0% | +$35.7K | 0.01% | 963 |
|
|
2015
Q4 | $115M | Buy |
2,030,765
+58,585
| +3% | +$3.31M | 0.02% | 763 |
|
|
2015
Q3 | $78.5M | Sell |
1,972,180
-51,928
| -3% | -$2.07M | 0.01% | 976 |
|
|
2015
Q2 | $96.7M | Sell |
2,024,108
-115,388
| -5% | -$5.51M | 0.02% | 905 |
|
|
2015
Q1 | $85M | Buy |
2,139,496
+100,980
| +5% | +$4.01M | 0.01% | 1017 |
|
|
2014
Q4 | $45.5M | Sell |
2,038,516
-37,226
| -2% | -$832K | 0.01% | 1358 |
|
|
2014
Q3 | $32.5M | Sell |
2,075,742
-3,748
| -0.2% | -$58.7K | 0.01% | 1553 |
|
|
2014
Q2 | $30.8M | Sell |
2,079,490
-4,359
| -0.2% | -$64.7K | 0.01% | 1654 |
|
|
2014
Q1 | $33.6M | Buy |
2,083,849
+144,026
| +7% | +$2.32M | 0.01% | 1590 |
|
|
2013
Q4 | $18.1M | Sell |
1,939,823
-188,908
| -9% | -$1.76M | ﹤0.01% | 2014 |
|
|
2013
Q3 | $24.1M | Buy |
2,128,731
+234,911
| +12% | +$2.66M | ﹤0.01% | 1722 |
|
|
2013
Q2 | $25.3M | Buy |
+1,893,820
| New | +$25.3M | 0.01% | 1623 |
|